HLUKF - H. Lundbeck scoops up Abide for ~$400M including milestone payment May, 06 2019 02:06 PM H Lundbeck A/S Denmark’s H. Lundbeck (OTC:HLUKF) snaps up Abide Therapeutics and adds differentiated chemo-proteomic discovery platform and a US-based research hub.More news on: H. Lundbeck A/S, H. Lundbeck A/S, Healthcare stocks news, Merger & acquisition news, Read more ...